Decoy Therapeutics Inc. Contract Liability (Deferred Revenue)
Decoy Therapeutics Inc. (DCOY) had Contract Liability (Deferred Revenue) of $0 as of 2020-12-31, per its 10-K filed 2021-03-18.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2021-03-18
- 2020-12-31: Contract with Customer, Liability, Current $0.00.
- 2020-09-30: Contract with Customer, Liability, Current $0.00.
- 2020-06-30: Contract with Customer, Liability, Current $0.00.
- 2020-03-31: Contract with Customer, Liability, Current $0.00.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-18 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-12 |
| 2020-03-31 | $0.00 10-Q/A · filed 2020-05-15 |
| 2019-12-31 | $541.70K 10-K · filed 2021-03-18 |
| 2019-09-30 | $1.58M 10-Q · filed 2019-11-12 |
| 2018-12-31 | $4.01M 10-K · filed 2020-03-23 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-05 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-01 |
| 2017-12-31 | $72.19K 10-Q · filed 2018-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |